Pharmaceuticals

Growth Of The Parathyroid Hormone Market Driven By Increasing Geriatric Population Is Supporting Development Across The Parathyroid Hormone Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Parathyroid Hormone Market Compare Between 2026 And 2030?

The parathyroid hormone market has seen rapid expansion in recent years. Its value is expected to grow from $2.51 billion in 2025 to $2.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.5%. Historically, this growth can be attributed to several factors including the restricted availability of recombinant parathyroid hormone, limited disease awareness among patients, a reliance on conventional vitamin D therapy, the development of hospital and clinic infrastructure, and an increase in post-surgical parathyroid complications.

The parathyroid hormone market is projected to experience substantial expansion in the coming years. It is anticipated to reach a valuation of $4.4 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.9%. This growth during the forecast period is primarily driven by the development of advanced parathyroid hormone analogues, the rising adoption of personalized medicine approaches, the expansion of hospital and specialty clinics, the integration of digital patient monitoring tools, and increasing government and healthcare initiatives aimed at hypocalcemia and hypoparathyroidism. Prominent trends expected in this period include a rising incidence of hypocalcemia and hypoparathyroidism, the increasing use of recombinant parathyroid hormone therapies, the proliferation of parathyroid hormone analogues for personalized treatment, the expansion of hospital and clinic-based parathyroid care programs, and a strong focus on post-surgical management and vitamin D supplementation.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

What Market Drivers Are Helping Shape The Parathyroid Hormone Market Expansion?

The rising elderly demographic is anticipated to stimulate the future expansion of the parathyroid hormone market. This group encompasses older adults, typically 65 years and older, who frequently encounter age-related health issues and necessitate specialized care and assistance. This demographic shift stems from extended life expectancies, advancements in medical care, and reduced birth rates, leading to a higher proportion of older individuals in society. Parathyroid hormone is essential for the geriatric population due to its role in regulating calcium levels and bone metabolism, aiding in the prevention of osteoporosis and fractures, which are common among seniors. For instance, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, reported that the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. This age group’s proportion of the overall population is also projected to increase from 17% to 23% during the same period. Hence, the growing geriatric population is propelling the growth of the parathyroid hormone market.

Which Segment Divisions Form The Structure Of The Parathyroid Hormone Market?

The parathyroid hormone market covered in this report is segmented –

1) By Disease Type: Hypocalcemia, Hypoparathyroidism

2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency

2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism

What Trends Are Impacting The Parathyroid Hormone Market?

Leading companies operating in the parathyroid hormone market are concentrating on developing biosimilar versions of parathyroid-based drugs, including prodrugs of parathyroid hormone (PTH), to improve available treatment options. A prodrug of parathyroid hormone (PTH) is an inactive compound that converts into active parathyroid hormone upon administration, allowing for sustained release and consistent therapeutic results for calcium regulation and bone health. For example, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, announced that the Food & Drug Administration (FDA) approved YORVIPATH (palopegteriparatide) as the initial and sole treatment for hypoparathyroidism in adults. This once-daily prodrug ensures continuous exposure to PTH, benefiting an estimated 70,000 to 90,000 patients in the United States. Ascendis Pharma, the manufacturer, offers patient assistance via its ascendis signature access program (A.S.A.P.) program, although users must routinely monitor serum calcium levels for potential hypercalcemia or hypocalcemia.

Which Companies Form The Competitive Landscape Of The Parathyroid Hormone Market?

Major companies operating in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited

Access The Complete Parathyroid Hormone Market Report:

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Which Region Contributes The Most To The Parathyroid Hormone Market?

North America was the largest region in the parathyroid hormone market in 2025. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Parathyroid Hormone Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

Browse Through More Reports Similar to the Global Parathyroid Hormone Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Drugs For Hormonal Replacement Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Thyroid Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795